Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

774
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
774

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ameliorated potential and possible mechanisms of medicine food homology for depression.

3 Biotech·2026
Same author

Prognostic significance of pretreatment pan-immune inflammation value in esophageal squamous cell carcinoma patients undergoing definitive chemoradiotherapy.

BMC cancer·2026
Same author

Tumor Necrosis Factor Superfamily 14: A Potential Predictor of Atrial Fibrillation Recurrence After Catheter Ablation.

Clinical cardiology·2026
Same author

Enzymatic Cascade-Powered Urinary Diagnostics for Visual Cancer Monitoring.

ACS nano·2026
Same author

High-Entropy Alloy Synergized with Gene Editing for Cocktail-Sensitized Radioimmunotherapy of Lung Metastases.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

Tough, highly conductive and flame-retardant MXene/NR films based on large-sized MXene sheets for efficient electromagnetic interference shielding.

Nanoscale·2026
Same journal

A Muscle-Mimetic Core-Sheath Composite Yarn Scaffold for In-Body Tissue Induction and Regeneration of Small-Diameter Vascular Grafts.

Advanced healthcare materials·2026
Same journal

Gardiquimod Nanoemulsion Targets Cutaneous Leishmaniasis Lesions Reducing Systemic Toxicity and Parasite Burden.

Advanced healthcare materials·2026
Same journal

Therapeutic Extracellular Vesicles from Synovial Fibroblast-Primed MSCs for Osteoarthritis Treatment.

Advanced healthcare materials·2026
Same journal

Natural Polysaccharide-Mediated Nano-Delivery Systems for Osteoporosis Therapy From a Gut-Bone Axis Regulatory Perspective.

Advanced healthcare materials·2026
Same journal

A Corrigendum on "Selenium-Albumin Nanoaccelerator Hydrogel Promotes Wound Healing by Antibacterial, Anti-Inflammatory and Antioxidant along with Inhibits Scar Formation via Down-regulating CD36".

Advanced healthcare materials·2026
Same journal

High-Throughput Digital Decoding of Vascular Heterogeneity in Patient-Specific Tumor Microenvironments.

Advanced healthcare materials·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
10:16

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

2.0K

Engineered Biomarkers for Point-of-Care Diagnostics.

Lu Wang1,2, Dongtao Zhou2, Chao Teng1

  • 1Institute of Critical Materials for Integrated Circuits, Shenzhen Polytechnic University, Shenzhen, 518055, China.

Advanced Healthcare Materials
|November 10, 2025
PubMed
Summary
This summary is machine-generated.

Engineered biomarkers combined with point-of-care (POC) platforms offer sensitive and specific early disease detection. This approach enhances accessibility and streamlines diagnostics for improved patient outcomes.

Keywords:
early diagnosisengineered biomarkermicrofluidicspersonalized medicinepoint‐of‐care

More Related Videos

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
13:42

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

12.4K
Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging
04:33

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Published on: December 8, 2023

1.4K

Related Experiment Videos

Last Updated: Jan 11, 2026

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
10:16

Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases

Published on: August 16, 2024

2.0K
Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation
13:42

Dry Film Photoresist-based Electrochemical Microfluidic Biosensor Platform: Device Fabrication, On-chip Assay Preparation, and System Operation

Published on: September 19, 2017

12.4K
Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging
04:33

Author Spotlight: Engineering Molecular Tools for Disease Detection and Imaging

Published on: December 8, 2023

1.4K

Area of Science:

  • Biomarkers and Diagnostics
  • Nanotechnology in Medicine
  • Point-of-Care Testing

Background:

  • Traditional biomarkers lack sensitivity, specificity, and early detection capabilities.
  • Engineered biomarkers leverage bioengineering, chemistry, and nanotechnology to amplify signals.
  • Limitations of traditional methods hinder timely disease management and patient outcomes.

Purpose of the Study:

  • To review advancements in engineered biomarkers for point-of-care (POC) detection.
  • To explore applications of engineered biomarkers across various diseases.
  • To examine challenges and future directions for clinical translation.

Main Methods:

  • Review of recent literature on engineered biomarkers and POC platforms.
  • Analysis of design strategies for enhanced sensitivity and specificity.
  • Examination of clinical transformation challenges and future research avenues.

Main Results:

  • Engineered biomarkers integrated with POC platforms significantly improve diagnostic sensitivity and specificity.
  • POC platforms enable rapid, accessible disease detection in diverse settings.
  • The combined approach overcomes limitations of traditional diagnostic methods.

Conclusions:

  • Engineered biomarkers and POC platforms represent a significant advancement in early disease diagnosis.
  • Further development is needed to address clinical transformation challenges.
  • This technology holds promise for personalized medicine and improved global health outcomes.